Skip to search.
 TSX Down 0.16% TSX Ventures  0.00%
Streaming
Ticker Tape: On

More On TKM.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Tekmira Pharmaceuticals Corp (TKM.TO)

-Toronto
16.54 Down 0.13(0.78%) 4:00PM EDT
Add to Portfolio
Prev Close:16.67
Open:16.91
Bid:16.26
Ask:16.80
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:16.27 - 17.24
52wk Range:4.58 - 34.66
Volume:75,173
Avg Vol (3m):145,037
Market Cap:325.66M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.54
Quarterly EPS Est (Mar-14) :0.16
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Tekmira Pharmaceuticals Corporation, a biopharmaceutical company, focuses on the research and development of RNA interference therapeutics; and provides lipid nanoparticle delivery technology to pharmaceutical partners in Canada. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback